Approval · Notice of Compliance 5202 · 1995
FLOXIN: Notice of Compliance 5202
Issued December 28, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5202
- Date
- December 28, 1995
- Company
- Ortho-Mcneil Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: treatment of acute pelvic inflammatory disease of mild to moderate severity appropriate for outpatient management
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLOXIN | Not yet assigned | — |